(Q37077649)

18 August 2017

1 reference

title

Genetically engineered Tobacco mosaic virus as nanoparticle vaccines (English)

1 reference

18 August 2017

0 references

Tobacco mosaic virus

1 reference

Alison A McCormick

1

1 reference

18 August 2017

Kenneth E Palmer

series ordinal

2

1 reference

18 August 2017

publication date

1 February 2008

1 reference

Expert Review of Vaccines

18 August 2017

published in

1 reference

18 August 2017

volume

7

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

33-41

1 reference

Milestones in the research on tobacco mosaic virus

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Beijerinck's work on tobacco mosaic virus: historical context and legacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Die Sichtbarmachung von pflanzlichem Virus im �bermikroskop

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

The structure of tobacco mosaic virus. I. X-ray evidence of a helical arrangement of sub-units around the longitudinal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

The antigenicity of tobacco mosaic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Comparative immunogenicities of tobacco mosaic virus, protein subunits, and reaggregated protein subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

The differential immunogenicity of plant viral protein and nucleoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Self-assembly of tobacco mosaic virus: the role of an intermediate aggregate in generating both specificity and speed

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Immunologic mechanisms of antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Improving vaccine performance with adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Designing recombinant vaccines with viral properties: a rational approach to more effective vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Immunity in response to particulate antigen-delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Ins and outs of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Dendritic cells: immunobiology and cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

The cross-priming pathway: a portrait of an intricate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Cross-presentation: underlying mechanisms and role in immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Cellular mechanisms governing cross-presentation of exogenous antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

The interface between innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Mechanisms of MHC class I-restricted antigen processing and cross-presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Targeting antigens to dendritic cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Vaccines that facilitate antigen entry into dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Display of epitopes on the surface of tobacco mosaic virus: impact of charge and isoelectric point of the epitope on virus-host interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Immunoabsorbent nanoparticles based on a tobamovirus displaying protein A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Malarial epitopes expressed on the surface of recombinant tobacco mosaic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Plant virus expressing hybrid coat protein with added murine epitope elicits autoantibody response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Virus-like particles: flexible platforms for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

A modified TMV-based vector facilitates the expression of longer foreign epitopes in tobacco

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Expression of foot-and-mouth disease virus epitopes in tobacco by a tobacco mosaic virus-based vector*1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Affinity purification of streptavidin using tobacco mosaic virus particles as purification tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Self-assembling light-harvesting systems from synthetically modified tobacco mosaic virus coat proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Chemical conjugate TMV-peptide bivalent fusion vaccines improve cellular immunity and tumor protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Expression of tobacco mosaic virus coat protein and assembly of pseudovirus particles in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

Immunization with a chimeric tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with P. aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.33

21 January 2018

Identifiers

DOI

10.1586/14760584.7.1.33

1 reference

18 August 2017

1 reference